openPR Logo
Press release

Anlon launches gel based Torrid Plus for instant pain relief

07-04-2018 02:04 PM CET | Health & Medicine

Press release from: www.anlon.in

Anlon launches gel based Torrid Plus for instant pain relief

Anlon launches gel based Torrid Plus for instant pain relief

Ahmedabad (Gujarat, India), Wednesday, July 4, 2018: Keeping the football fever on during the ongoing FIFA World Cup, Rajkot based pharmaceuticals startup, Anlon Lifescience has launched over-the-counter “Torrid - Plus” for instant pain relief here on today. The gel based instant pain reliever works like a wonder on joints pain, sprains and strains, muscular pain, lower back pain and neck pain.

Commenting on the launch, Mr. Punit Rasadia, Managing Director of Anlon Lifescience, said that Indian youths love playing football and with the ensuing monsoon season, football would be played everywhere. “There are chances, football players of our country may sustain muscle or bone injuries or sprains and strains while playing football but our product- Torrid-Plus can provide instant relief on muscular and joint pain.”

Talking on the advantages of the product, Mr. Rasadia said that Torrid-Plus is gel based and is not cream based like other pain relievers available in the market. As Torrid-Plus is gel based, it gets absorbed with the skin easily and starts working without leaving a mark of medicine.

After conducting thorough market study, continued Mr. Rasadia, we have developed the product which is useful for all generations from youth to middle aged to elderly people of our country. Now-a-days, young generations are more exposed to digital gadgets including mobile phones and laptops or computers. Over using of digital gadgets with wrong postures are leading to neck and lower back pain to youths. But our product, Torrid-Plus can provide instant relief to neck and lower back pain. Similarly, Torrid-Plus is also very useful for middle aged men and women and elderly people to get relieved while experiencing joints pain mainly on knees and lower back pain mainly on spinal cord.

Mr. Rasadia informed that key ingredients of Torrid-Plus are Diclofenac, Methyl Salicylate and Menthol Gel. Diclofenac is a proven non steroidal anti inflammatory drug which has profound therapeutic effect on joint pain, osteoarthritis, and sprained knee. The drug reduces pain by decreasing inflammation while Methyl Salicylate and Menthol Gel act as counterirritant by providing cold and hot sensations on skin and thus reduce effect of pain and provide relieves of muscular ache.

“The product is available over the counter (OTC) and can be purchased from medical stores without any prescription from any medical practitioner,” Mr. Rasadia announced.

ANLON Group is a research-intensive organization is into manufacturing of APIs and intermediates, process control instruments and pharmaceutical products.

Based in Rajkot in Gujarat in India, ANLON Group has already earned a global recognition for manufacturing products that adhere to the highest standards of quality. ANLON Group has three major divisions - Anlon Healthcare Private Limited is into manufacturing of API and its intermediates, while Anlon Technology Research Organization is into manufacturing of process control and automation instruments and Anlon Lifescience Private Limited is engaged into multi dimensional modern pharmaceutical products.

Anlon, 101/102-Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot 360 005, Gujarat, India, Phone: +91 - 281-2561340, 2562538/39

Media: RocketScienceIdea, D-101, Titanium City Centre, Opp Seema Hall, Prahladnagar Road, Ahmedabad 380 015, Gujarat, India. Email: media@anlon.in

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anlon launches gel based Torrid Plus for instant pain relief here

News-ID: 1109439 • Views:

More Releases for Torrid

Plus Size Bras Market is Going to Boom | Major Giants Lane Bryant, Torrid, Playt …
HTF MI recently introduced Global Plus Size Bras Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. Major companies in Plus Size Bras Market are: Triumph International (Germany), Lane Bryant Brands Opco LLC (United States), Wacoal Direct Corp. (United
Investigation announced for Investors in Torrid Holdings Inc. (NYSE: CURV) over …
An investigation was announced for current long-term investors in shares of Torrid Holdings Inc. (NYSE: CURV) concerning potential breaches of fiduciary duties by certain directors and officers of Torrid Holdings Inc.. Investors who are current long term investors in Torrid Holdings Inc. (NYSE: CURV) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long
Deadline in Lawsuit for Investors in Torrid Holdings Inc. (NYSE: CURV ) coming u …
A deadline is coming up in the lawsuit filed for certain investors of Torrid Holdings Inc. (NYSE: CURV) over alleged securities laws violations by Torrid Holdings Inc. Investors who purchased shares of Torrid Holdings Inc. (NYSE: CURV) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the complaint filed in the in the U.S. District Court for the Central District of California
Lawsuit filed for Investors who lost money with shares of Torrid Holdings Inc. ( …
An investor, who purchased shares of Torrid Holdings Inc. (NYSE: CURV), filed a lawsuit over alleged Securities Laws violations by Torrid Holdings Inc. in connection with certain allegedly false and misleading statements made in connection with the Company's July 2021 initial public offering (the "IPO"). If you purchased shares of Torrid Holdings Inc. (NYSE: CURV), you have certain options and for certain investors are short and strict deadlines running. Deadline: January
Investigation announced for Investors in Torrid Holdings Inc (NYSE: CURV) over p …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Torrid Holdings Inc. Investors who purchased shares of Torrid Holdings Inc (NYSE: CURV) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Torrid Holdings Inc directors breached their fiduciary duties and caused damage to the company and its shareholders. City
Investigation for Investors in shares of Torrid Holdings Inc (NYSE: CURV) over p …
An investigation was announced for investors of Torrid Holdings Inc (NYSE: CURV) shares over potential securities laws violations by Torrid Holdings Inc. Investors who purchased shares of Torrid Holdings Inc (NYSE: CURV), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Torrid Holdings Inc (NYSE: CURV)